Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Chemo-Immunotherapy in Patients With Relapsed and Refractory Head and Neck Squamous Cell Carcinoma

NCT01149902 is registered in ClinicalTrials.gov with University of Yamanashi as lead sponsor.

NCT NCT01149902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01149902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Chemo-Immunotherapy in Patients With Relapsed and Refractory Head and Neck Squamous Cell Carcinoma
Lead sponsor
University of Yamanashi
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2010
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer